Prices delayed by at least 15 minutes | Print
OSE IMMUNO (OSE)
OSE IMMUNOTHERAPEUTICSOpen
€7.52
Previous close
€7.54
Trade high
€7.8
Volume
212,142
Year high
€7.80
Year low
€2.71
Dividend yield
-
Market capitalisation
€160.97 mn
P/E ratio
-
ISIN
FR0012127173
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Company profile
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.